Dexcom (DXCM) Cash from Investing Activities Growth (3y) (2013 - 2026)
Dexcom (DXCM) Cash from Investing Activities Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.50 Bn | 194.89 Bn | 7.27 Bn | 17.83% |
| 2 | Stryker | 130.00 Bn | 126.52 Bn | 4.50 Bn | -6.23% |
| 3 | Medtronic | 120.36 Bn | 111.14 Bn | 6.41 Bn | -24.52% |
| 4 | Boston Scientific | 74.19 Bn | 73.65 Bn | 3.85 Bn | -32.54% |
| 5 | Edwards Lifesciences | 52.73 Bn | 48.48 Bn | 1.35 Bn | -68.12% |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | 37.39% |
| 7 | GE HealthCare Technologies | 34.13 Bn | 32.02 Bn | 2.18 Bn | -11.04% |
| 8 | Koninklijke Philips | 26.52 Bn | 23.20 Bn | 4.55 Bn | 19.58% |
| 9 | Steris | 23.23 Bn | 22.75 Bn | 684.20 Mn | -17.67% |
| 10 | Zimmer Biomet Holdings | 19.39 Bn | 18.98 Bn | 1.54 Bn | 7.76% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 37.39% |
| Mar 31, 2026 | -16.93% |
| Dec 31, 2025 | 52.97% |
| Sep 30, 2025 | -5.62% |
| Jun 30, 2025 | 24.00% |
| Mar 31, 2025 | 30.91% |
| Dec 31, 2024 | 15.09% |
| Sep 30, 2024 | 93.56% |
| Jun 30, 2024 | -36.08% |
| Mar 31, 2024 | 38.67% |
| Dec 31, 2023 | 168.18% |
| Sep 30, 2023 | -168.24% |
| Jun 30, 2023 | 20.71% |
| Mar 31, 2023 | -50.80% |
| Dec 31, 2022 | -27.21% |
| Sep 30, 2022 | 36.72% |
| Jun 30, 2022 | 39.03% |
| Mar 31, 2022 | -72.54% |
| Dec 31, 2021 | -162.34% |
| Sep 30, 2021 | 84.73% |